Melinta Therapeutics

Melinta Therapeutics is a company listed under the stock ticker MLNT (US).

View the org chart displaying its 12 main executives

Most searched biographies at Melinta Therapeutics

• Christine Miller, President,Chief Executive Officer and Director
• Sumner Anderson, Director
• Bryan Sendrowski, Director

Create your alert
to follow the executive moves at Melinta Therapeutics.

Melinta Therapeutics has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Melinta Therapeutics

• News - Melinta
• News - Melinta
• RSS News Feeds | Melinta Therapeutics, Inc.
• Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase | Melinta Therapeutics, Inc.
• Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals | Melinta Therapeutics, Inc.
• Melinta Therapeutics Successfully Completes Financial Restructuring | Melinta Therapeutics, Inc.
• Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company | Melinta Therapeutics, Inc.
• Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures | Melinta Therapeutics, Inc.
• Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility | Melinta Therapeutics, Inc.
• Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update | Melinta Therapeutics, Inc.
• View more press releases Close

Social media about Melinta Therapeutics

• Melinta Therapeutics on Wikipedia, Google News & Yahoo Finance
• Melinta Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Christine Miller

Call Melinta Therapeutics at +1 203...

View the org chart

Register to receive your alert

Report an error